Search Filters Year Year20242023202220212020201920182017201620152014201320122011201020092008 Topic TopicAssessmentClinical guideline supportCOVID-19 reportGeneric justificationGuidelines/guidance COVID-19 Topics COVID-19 TopicsChildren and vulnerable peopleDiagnosis, testing and epidemiologyImmunityPublic health and policy guidanceService deliveryTransmission and preventionTreatment and vaccination Keyword Search ¹⁷⁷Lutetium PSMA radioligand therapy for the treatment of metastatic castrate-resistant prostate cancer: Evidence synthesis to support a generic justification decision Status: Published on 26 Apr 2024 Download Document Download infographic Download